March 10, 2008
Kyowa Hakko Kogyo announced on February 28 that its wholly owned US subsidiary Kyowa Pharmaceutical, Inc., received on February 25 a not-approvable letter from the FDA for its investigational drug for the treatment of Parkinson's disease istradefylline (KW-6002). An NDA...read more